OBEN

Presse

Gen Re Releases 2025 U.S. Individual Disability Market Survey Results

Ausgabe: Mai 2026 | Life/Health North America

Carriers Reported Mixed Results for Individual Disability Insurance Sales

Stamford, CT, May 27, 2026 – Gen Re recently released its U.S. Individual Disability Market Survey which captures Non-Cancelable, Guaranteed Renewable, Guaranteed Standard Issue, and Buy-Sell new sales and inforce results. Sixteen carriers participated in the survey, reporting $5.6 billion in inforce premium, an increase of 1.9% over 2024 results. New sales were up 2.7% to $491.8 million, while the number of new policies written increased 0.7% year over year.

Additional highlights from this annual benchmark report include:

  • By product line, Non-Cancelable inforce premium grew 2.0% to $4.7 billion, representing 85% of total inforce premium. Guaranteed Renewable inforce premium grew 2.2% to $793.7 million, while Buy-Sell premium declined 7.0% to $41.8 million, trending down for the 17th consecutive year.
  • Non-Cancelable new sales premium grew 3.8%, while Guaranteed Renewable fell 4.3%. Buy-Sell new sales premium increased 10.4% in 2025, bouncing back from a decline of 23.9% in 2024.
  • The total number of policies inforce remained level at 3.0 million, decreasing by 0.2%, while the total number of new policies issued showed a slight increase at 0.7%. New Non-Cancelable policies grew 3.8%, while Guaranteed Renewable policies fell 3.9%.
  • The GSI market had another strong year with premium and the number of policies sold up year over year.

The Market Survey is an annual benchmark survey produced by Gen Re, with the full results available only to participating companies. A summary report is available here.

Gen Re, a Berkshire Hathaway Company, is one of the leading Life & Health and Property & Casualty reinsurers in the world. Our North American Life & Health reinsurance company, General Re Life Corporation, has superior financial strength ratings among Life and Health reinsurers. Gen Re delivers customized reinsurance programs and risk management solutions for the Life, Medicare Supplement, Critical Illness and Individual Disability Income markets. Through our research, we also offer valuable information and insights.

Kontacte